A new era for children with diffuse intrinsic pontine glioma: Hope for cure?

Expert Review of Anticancer Therapy

Volumn 12, Issue 9, 2012, Pages 1109-1112

  Kaspers, Gertjan J ^a   Jansen, Marc Ha ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

animal model; biology; blood brain barrier; brain stem; drug delivery; glioma; pontine glioma; system; therapeutic

Indexed keywords

BRADYKININ; CARBOPLATIN; HISTONE H3; INTERLEUKIN 13; MANNITOL; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 124I 8H9; NIMUSTINE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PSEUDOMONAS EXOTOXIN; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG; ZIRCONIUM;

AUTOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER TISSUE; CHILD; CHILDHOOD CANCER; CHROMOSOME 1; DRUG DISTRIBUTION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PONTINE GLIOMA; PROGNOSIS; REVIEW; TUMOR BIOPSY;

ANTINEOPLASTIC AGENTS; BRAIN STEM NEOPLASMS; CHILD; DRUG DELIVERY SYSTEMS; DRUG THERAPY, COMBINATION; DRUGS, INVESTIGATIONAL; FORECASTING; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; PONS; RADIOTHERAPY; THERAPIES, INVESTIGATIONAL;

EID: 84867959387     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.12.95     Document Type: Review

References (27)

1. Kaatsch P, Rickert CH, Kühl J, Schüz J, Michaelis J. Population-based epidemiologic data on brain tumors in German children. Cancer 92(12), 3155-3164 (2001). (Pubitemid 33136212)
2. Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol. 7(3), 241-248 (2006). (Pubitemid 43286454)
3. Jansen MH, van Vuurden DG, Vandertop WP, Kaspers GJ. Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology. Cancer Treat. Rev. 38(1), 27-35 (2012).
4. Janssens GO, Jansen MH, Lauwers SJ et al. Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis. Int. J. Radiat. Oncol. Biol. Phys. doi:10.1016/j.ijrobp.2012.04.006 (2012) (Epub ahead of print).
5. Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD. Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group. Neurosurgery 33(6), 1026-1029; discussion 1029 (1993).
6. Pincus DW, Richter EO, Yachnis AT, Bennett J, Bhatti MT, Smith A. Brainstem stereotactic biopsy sampling in children. J. Neurosurg. 104(Suppl. 2), 108-114 (2006). (Pubitemid 44968440)
7. Roujeau T, Machado G, Garnett MR et al. Stereotactic biopsy of diffuse pontine lesions in children. J. Neurosurg. 107(Suppl. 1), 1-4 (2007).
8. Angelini P, Hawkins C, Laperriere N, Bouffet E, Bartels U. Post mortem examinations in diffuse intrinsic pontine glioma: challenges and chances. J. Neurooncol. 101(1), 75-81 (2011).
9. Broniscer A, Baker JN, Baker SJ et al. Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma. Cancer 116(19), 4632-4637 (2010).
10. Paugh BS, Broniscer A, Qu C et al. Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J. Clin. Oncol. 29(30), 3999-4006 (2011).
11. Paugh BS, Qu C, Jones C et al. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J. Clin. Oncol. 28(18), 3061-3068 (2010).
12. Barrow J, Adamowicz-Brice M, Cartmill M et al. Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas. Neuro Oncol. 13(2), 212-222 (2011).
13. Puget S, Philippe C, Bax DA et al. Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS ONE 7(2), e30313 (2012).
14. Warren KE, Killian K, Suuriniemi M, Wang Y, Quezado M, Meltzer PS. Genomic aberrations in pediatric diffuse intrinsic pontine gliomas. Neuro-oncology 14(3), 326-332 (2012).
15. Zarghooni M, Bartels U, Lee E et al. Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights plateletderived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets. J. Clin. Oncol. 28(8), 1337-1344 (2010).
16. Wu G, Broniscer A, McEachron TA et al.; St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet. 44(3), 251-253 (2012).
17. Monje M, Mitra SS, Freret ME et al. Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. Proc. Natl Acad. Sci. USA 108(11), 4453-4458 (2011).
18. Stupp R, Mason WP, van den Bent MJ et al.; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352(10), 987-996 (2005). (Pubitemid 40349501)
19. Pollack IF, Jakacki RI, Blaney SM et al. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report. Neuro-oncology 9(2), 145-160 (2007). (Pubitemid 46580316)
20. Poussaint TY, Kocak M, Vajapeyam S et al. MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro-oncology 13(4), 417-427 (2011).
21. Caretti V, Zondervan I, Meijer DH et al. Monitoring of tumor growth and postirradiation recurrence in a diffuse intrinsic pontine glioma mouse model. Brain Pathol. 21(4), 441-451 (2011).
22. Thirant C, Bessette B, Varlet P et al. Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors. PLoS ONE 6(1), e16375 (2011).
23. van Dongen GA, Visser GW, Lub-de Hooge MN, de Vries EG, Perk LR. Immuno- PET: a navigator in monoclonal antibody development and applications. Oncologist 12(12), 1379-1389 (2007).
24. Hall WA, Doolittle ND, Daman M et al. Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas. J. Neurooncol. 77(3), 279-284 (2006). (Pubitemid 44404394)
25. Packer RJ, Krailo M, Mehta M et al. A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas. Cancer 104(9), 1968-1974 (2005). (Pubitemid 41513182)
26. Lonser RR, Warren KE, Butman JA et al. Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. J. Neurosurg. 107(1), 190-197 (2007). (Pubitemid 47026491)
27. Saito R, Sonoda Y, Kumabe T, Nagamatsu K, Watanabe M, Tominaga T. Regression of recurrent glioblastoma infiltrating the brainstem after convectionenhanced delivery of nimustine hydrochloride. J. Neurosurg. Pediatr. 7(5), 522-526 (2011).